Atherosclerosis in scavenger receptor deficient APOE3Leiden transgenic mice

被引：0
|
作者：
deWinther, MPJ [1 ]
Gijbels, MJJ [1 ]
vanDijk, KW [1 ]
vanGorp, PJJ [1 ]
Kodama, T [1 ]
Frants, RR [1 ]
Havekes, LM [1 ]
Hofker, MH [1 ]
机构：
[1] LEIDEN UNIV,DEPT HUMAN GENET,TNO,GAUBIUS LAB,PG,NL-2300 RA LEIDEN,NETHERLANDS
来源：
ATHEROSCLEROSIS | 1997年 / 134卷 / 1-2期
关键词：
D O I：
10.1016/S0021-9150(97)88259-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [21] Salicylamine, A γ-ketoaldehyde Scavenger, Improves HDL Function and Reduces Atherosclerosis in Apoe Deficient Mice
    Huang, Jiansheng
    Yancey, Patricia
    Ding, Lei
    Zhang, Youmin
    Oates, John
    Amarnath, Venkataraman
    Roberts, Jackson
    Davies, Sean
    Linton, MacRae F.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37
  • [22] Macrophage p53 deficiency leads to enhanced atherosclerosis in APOE*3-Leiden transgenic mice
    van Vlijmen, BJM
    Gerritsen, G
    Franken, AL
    Boesten, SM
    Kockx, MM
    Gijbels, MJ
    Vierboom, MP
    van Eck, M
    van de Water, B
    van Berkel, TJC
    Havekes, LM
    CIRCULATION RESEARCH, 2001, 88 (08) : 780 - 786
  • [23] Quantitative assessment of aortic atherosclerosis in APOE*3 Leiden transgenic mice and its relationship to serum cholesterol exposure
    Groot, PHE
    vanVlijmen, BJM
    Benson, GM
    Hofker, MH
    Schiffelers, R
    VidgeonHart, M
    Havekes, LM
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (08) : 926 - 933
  • [24] THE EFFECT OF ALISKIREN ON ATHEROSCLEROSIS DEVELOPMENT IN APOE*3LEIDEN.CETP TRANSGENIC MICE WITH AND WITHOUT TREATMENT WITH ATORVASTATIN
    Jordaan, S.
    van der Hoorn, J. W. A.
    Havekes, L. M.
    Liau, G.
    Jukema, J. W.
    Princen, H. M. G.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 31 - 31
  • [25] Involvement of C-reactive protein in atherosclerosis development in ApoE*3-Leiden/hCRP transgenic mice
    Trion, A
    De Maat, MPM
    Jukema, JW
    Van der Laarse, A
    Emeis, JJ
    EUROPEAN HEART JOURNAL, 2004, 25 : 153 - 153
  • [26] The Effect of Aliskiren on Atherosclerosis Development in APOE*3Leiden.CETP Transgenic Mice with and Without Atorvastatin Treatment
    Van der Hoorn, Jose W.
    Jordaan, Susan
    Havekes, Louis M.
    Liau, Gene
    Jukema, J. W.
    Princen, Hans M.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (11) : E292 - E292
  • [27] Inhibition of accelerated atherosclerosis in vein grafts by placement of external stent in ApoE*3-Leiden transgenic mice
    Lardenoye, JHP
    de Vries, MR
    Grimbergen, JM
    Havekes, LM
    Knaapen, MWM
    Kockx, MM
    van Hinsbergh, VWM
    van Bockel, JH
    Quax, PHA
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (09) : 1433 - 1438
  • [28] Lipoprotein metabolism and atherosclerosis in APOE*3Leiden mice.
    Havekes, LM
    vanVlijmen, BJM
    Jong, MC
    vanDijk, KW
    Groot, P
    Hofker, MH
    ATHEROSCLEROSIS, 1997, 130 : 141 - 141
  • [29] The metabolism of VLDL remnants in ApoE*3-Leiden transgenic mice
    Havekes, LM
    vanVlijmen, BJM
    Jong, MC
    Groot, PHE
    Frants, RR
    Hofker, MH
    DRUGS AFFECTING LIPID METABOLISM: RISK FACTORS AND FUTURE DIRECTIONS, 1996, 10 : 263 - 270
  • [30] REDUCTION OF EXISTING ATHEROSCLEROTIC PLAQUES: LIPID-LOWERING AND ANTI-INFLAMMATORY STRATEGIES PROMOTE LESION REGRESSION IN APOE3LEIDEN TRANSGENIC MICE
    Wielinga, P. Y.
    Kleemann, R.
    de Vries-Vd Weij, J.
    Toet, K.
    Rensen, P. C. N.
    Verschuren, L.
    Kooistra, T.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 177 - 177
12345